Sp275

BACTERIAL METABOLISM AND INTESTINAL DRUG ABSORPTION

Date
May 6, 2023
Explore related products in the following collection:

Society: AGA

Understand drug metabolism and disposition is critical to reduce patient morbidity and mortality. Explore the interplay between bacteria and the intestinal microenvironment unveils new knowledge of host-associated microbial communities that play a key role in the control drug metabolism. Review recent studies implicating gut microbes in the control of host drug transporters either directly, as well as through the direct metabolism of drugs or other aspects of drug disposition.

Presenter

Speaker Image for Beth McCormick
University of Massachusetts Medical School

Tracks

Related Products

Thumbnail for AGA Recent Advances in Understanding, Controlling and Treating Enteric Infections
AGA Recent Advances in Understanding, Controlling and Treating Enteric Infections
Infectious diarrhea is a leading cause of morbidity and of mortality globally. Enteric pathogens that are the cause of most severe acute diarrhea — as assessed by mortality — include Vibrio cholerae, Shigella spp., Salmonella spp., enteropathogenic E. coli(EPEC), and EAEC…
Thumbnail for PLACEHOLDER
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
Thumbnail for MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…